Investing

Evolution in Action

The world of investing is evolving, giving individuals the opportunity to invest in heretofore inaccessible, alternative assets.

Health+Tech

EnClear: Advancing Treatments for ALS and Neurodegenerative Diseases

EnClear Therapies is developing device-based systems to reduce or stop the progression of neurodegenerative diseases by eliminating the toxic proteins that provoke these conditions.

Health+Tech

Repair Biotechnologies is Tackling Longevity

The desire to prolong life and youthful vigor has existed for centuries without uniformly tangible results. Repair Biotechnologies offers to transform this desire into a reality.

Investing

Investing is Simple, Not Easy

Compounding, time , and above average returns are powerful forces in wealth creation. Angel investing gives you the ability to leverage them all.

Investing

Why Invest in Alternative Assets?

The Covid-19 pandemic has made healthcare the focus of our thoughts and emerging corporate innovation. Alternative assets are playing an ever greater role in this new focus.

Health+Tech

Ancilia Presentation and Q&A with CEO Alexandra Sakatos

Ancilia is a computational bio-platform company that engineers phage-resistant bacterial therapeutics utilizing CRISPR/Cas to treat microbiome-linked diseases including inflammatory bowel disease (IBD) and immunotherapy-associated colitis.

Octagon Therapeutics Presentation and Q&A with CEO Isaac Stoner

Octagon Therapeutics is developing targeted small molecules with selectivity towards autoimmune diseases

IVIVA Medical: Next Generation Human Tissue

IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state renal disease (ESRD). The IVIVA team is leveraging emerging complementary technologies in tissue engineering, 3D additive manufacturing, and stem cell biology in order to realize the potential of regenerative medicine to end donor organ shortage.

HepaTx is developing revolutionary stem cell-based therapies for liver disease

HepaTx is developing revolutionary stem cell-based therapies for liver disease

Health+Tech

The First Broad Spectrum Blood Test for Autism with BioROSA

Autism is the fastest growing neuro developmental disorder in the world, currently impacting 1 in 54 children in the U.S. and up to 3% of children worldwide.